natgillin/translations-raw huggingface dataset:
A serious hypersensitivity reaction including oedema of the eye, face, lips and throat (angioedema) has been reported rarely.
Redko so poročali o resnih preobčutljivostnih reakcijah, ki vključujejo edem očesa, obraza, ustnic in žrela (angioedem).
The starting dose of nebulised beclometasone dipropionate should take into account the frequency and severity of symptoms.
Pri določitvi začetnega odmereka beklometazondipropionata za nebulator je treba upoštevati pogostnost in resnost simptomov.
{INVENTED NAME} is indicated to treat asthma in adults and children up to 18 years of age when the use of pressurised or dry powder inhalers is unsatisfactory or inappropriate.
Zdravilo {IZMIŠLJENO IME} se uporablja za zdravljenje astme pri odraslih in otrocih do 18. leta starosti, kadar uporaba inhalatorjev pod tlakom ali inhalatorjev s suhim praškom ni zadovoljiva ali ni primerna.
If used concomitantly with systemic or intranasal steroids the suppressive effect on adrenal function will be additive.
Pri sočasni uporabi s sistemskimi ali intranazalnimi steroidi je zaviralni učinek na delovanje nadledvičnih žlez aditiven.
In the study 40.4% and 51.7% patients in the of nebulised beclometasone dipropionate and budesonide groups respectively did not experience any major exacerbation (primary endpoint).
Večjih poslabšanj v študiji ni imelo 40,4 % bolnikov v skupini z beklometazondipropionatom za nebulator in 51,7 % v skupini z budezonidom (to je bil primarni opazovani dogodek).
{INVENTED NAME} is not indicated to relieve acute asthma symptoms for which an inhaled shortacting beta 2-agonists is required.
Zdravilo {IZMIŠLJENO IME} ni indicirano za lajšanje akutnih simptomov astme, za katere je treba uporabiti kratkodelujoče beta2-agoniste.
Your doctor may decide that your dose should be diluted.
Redčenje Vaš zdravnik se bo morda odločil, da je treba odmerek razredčiti.
Infants and neonates born to mothers receiving substantial doses of beclometasone dipropionate during pregnancy should be observed for adrenal suppression.
Dojenčke in novorojenčke, rojene materam, ki so med nosečnostjo prejemale velike odmerke beklometazondipropionata, je treba opazovati zaradi možne supresije nadledvičnih žlez.
Besides evidence coming from long lasting use of inhaled beclometasone in the treatment of asthma and wheezing, the following data are a collection of the main supportive published data.
Poleg podatkov o dolgotrajni uporabi inhalacijskega beklometazona pri zdravljenju astme in piskajočega dihanja, so poznani naslednji podporni podatki, objavljeni v literaturi.
The 800 micrograms ampoule has a graduation mark to indicate half the content (corresponding to 400 micrograms).
800-mikrogramska ampula ima oznako za polovico vsebine (kar ustreza 400 mikrogramom).
After inhaling the prescribed dose patients should rinse their mouth with water to minimise the risk of oropharyngeal thrush (see section 4.4).
Po inhaliranju predpisanega odmerka si mora bolnik izprati usta, da zmanjša tveganje orofaringealne glivične okužbe (glejte poglavje 4.4).
If you have been treated for a long time with high doses of inhaled corticosteroid, you may require an extra corticosteroid treatment in times of stress.
Če dolgo časa uporabljate velike odmerke inhaliranih kortikosteroidov, boste v stresnih okoliščinah morda potrebovali več kortikosteroidov.
400 micrograms ampoule is for single use.
400 mikrogramska ampula je za enkratno uporabo.
Efficacy and safety of nebulised beclometasone dipropionate in the treatment of severe persistent asthma in infants and young children aged 6 months to 6 years, in comparison to budesonide suspension for nebulization was assessed in a multicentre, randomized, controlled open-labelled study for 14 weeks.
Učinkovitost in varnost beklometazondipropionata za nebulator pri zdravljenju hude trdovratne astme pri dojenčkih in majhnih otrocih, starih od 6 mesecev do 6 let, v primerjavi s suspenzijo budezonida za nebulator so ovrednotili v multicentrični, randomizirani, nadzorovani odprti študiji (potekala je 14 tednov).
It must be recommended that patients rinse their mouth with water immediately after inhalation to reduce the frequency of oral candidiasis.
Bolnikom je treba priporočiti, da si takoj po inhaliranju izperejo usta z vodo, da zmanjšajo pogostnost oralne kandidoze.
5 ampoules containing 1 ml suspension each
5 ampul, ki vsebujejo 1 ml suspenzije
Bend the ampoule backwards and forwards (Figure A).
Ampulo upogibajte nazaj in naprej (slika A).
Systemic effect of inhaled corticosteroids (including beclometasone dipropionate) may occur particularly when administered at high doses for prolonged periods of time: these may include adrenal suppression, decrease in bone mineral density, growth retardation in children and adolescents, cataract and glaucoma (see section 4.4).
Sistemski učinki inhaliranih kortikosteroidov (vključno z beklometazondipropionatom) se lahko pojavijo zlasti pri dajanju velikih odmerkov, uporabljenih v daljšem obdobju; ti lahko vključujejo supresijo nadledvičnih žlez, zmanjšanje mineralne gostote kosti, upočasnitev rasti pri otrocih in mladostnikih, katarakto in glavkom (glejte poglavje 4.4 ).
• throat irritation, hoarse voice
• draženje žrela, hripav glas,
The bioavailability of orally administered BDP is negligible but pre-systemic conversion to B17MP results in absorption of approximately 40% of the swallowed portion as B17MP.
Biološka uporabnost peroralno uporabljenega BDP je zanemarljiva, vendar se zaradi predsistemske pretvorbe v B17MP približno 40 % zaužitega odmerka B17MP absorbira.
• an allergic reaction (swelling of the eyes, face, lips and throat leading to severe difficulty in breathing, skin rashes, hives, itching or redness)
• alergijska reakcija (oteklost oči, obraza, ustnic in žrela, ki vodi v hude težave z dihanjem,
Store the ampoules in the upright position in the original package (carton box) in order to protect from light.
Ampule shranjujte v pokončnem položaju v originalni ovojnini (kartonski škatli) za zagotovitev zaščite pred svetlobo.
4.3 Contraindications Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Preobčutljivost za zdravilno učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1.
Talk to you doctor or pharmacist before using {INVENTED NAME} if any of the following applies to you:
Pred začetkom uporabe zdravila {IZMIŠLJENO IME} se posvetujte z zdravnikom ali farmacevtom, če kaj od naštetega velja za vas:
The manufacturer's instructions for use, maintenance and cleaning of the nebuliser must be followed.
Glede uporabe, vzdrževanja in čiščenja nebulatorja upoštevajte navodila izdelovalca.
In healthy males a single dose of 1600 µg beclometasone dipropionate by nebulisation had no effect on 24-h urinary cortisol excretion, while a single dose of 3200 µg produced a urinary cortisol excretion reduction of about 10% without any significant differences between the two dosage treatments.
24-urno izločanje kortizola v urinu, enkraten odmerek 3200 µg pa je povzročil zmanjšanje izločanja kortizola v urinu za približno 10 %; signifikantnih razlik med obema odmerjanjima ni bilo.
Following intravenous dosing, the disposition of BDP and its active metabolite, B17MP, are characterised by high plasma clearance (150 and 120 L/h respectively), with a small volume of distribution at steady state for BDP (20 L) and larger tissue distribution for its active metabolite (424 L).
in njegovega aktivnega presnovka, B17MP, značilen velik očistek v plazmi (150 oz. 120 L/h), z majhnim volumnom porazdelitve v stanju dinamičnega ravnovesja za BDP (20 L) in veliko porazdelitvijo v tkivu za aktivni presnovek (424 L).
Switching from corticosteroid tablets to {INVENTED NAME} Switching from corticosteroid tablets to an inhaled corticosteroid treatment might make you feel generally unwell or you might develop a rash, eczema or a runny nose and sneezing (rhinitis).
Prehod s kortikosteroidnih tablet na zdravilo {IZMIŠLJENO IME} Prehod s kortikosteroidnih tablet na inhalirano kortikosteroidno zdravljenje lahko povzroči splošno slabo počutje ali nastanek izpuščaja, ekcema, izcedka iz nosu in kihanja (rinitisa).
A double-blind, double-dummy, multicentre, randomized, parallel-group study compared the efficacy and safety of nebulised beclometasone dipropionate and beclometasone dipropionate administered with metered-dose inhalation in 151 patients, aged 6-16 years, with moderate to severe asthma for 4 weeks.
V dvojno slepi, dvojno zakriti, multicentrični, randomizirani študiji z vzporednimi skupinami so primerjali učinkovitost in varnost beklometazondipropionata za nebulator in beklometazonadipropionata, uporabljenega z odmernim inhalatorjem pri 151 bolnikih, starih od 6 do 16 let, z zmerno do hudo astmo (potekala je 4 tedne).
Use of {INVENTED NAME} with ultrasonic nebulisers is not recommended.
Uporaba zdravila {IZMIŠLJENO IME} z ultrazvočnim nebulatorjem ni priporočljiva.
There are strips 5 ampoules in each sealed pouch, in pack sizes of 10 ampoules (2 pouches), 20 ampoules (4 pouches) or 40 ampoules (8 pouches).
V vsaki zavarjeni vrečici je trak s 5 ampulami, na voljo so pakiranja z 10 ampulami (2 vrečici), 20 ampulami (4 vrečice) ali 40 ampulami (8 vrečic).
In case of bacterial infection of the respiratory tract an adequate antibiotic co-medication may be required.
Pri bakterijski okužbi dihal bo morda potrebna ustrezna sočasna antibiotična terapija.
Possible systemic effects include hypothalamic-pituitary-adrenal (HPA)-axis suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children).
(HPA; hypothalamic-pituitary-adrenal axis), upočasnitev rasti pri otrocih in mladostnikih, zmanjšanje mineralne gostote kosti, katarakta in glavkom in redkeje vrsta psiholoških ali vedenjskih učinkov, vključno s psihomotorično hiperaktivnostjo, motnjami spanja, anksioznostjo, depresijo ali agresijo
The container closed in this way must be stored at 2-8 C (in the refrigerator) and the remaining quantity has to be used within 12 hours after first opening.
Tako zaprto ampulo shranjujte pri 2◦C - 8◦C (v hladilniku); preostalo vsebino morate uporabiti v 12 urah po prvem odprtju.
Beclometasone dipropionate can be used during breast-feeding.
Beklometazondipropionat se lahko uporablja med dojenjem.
Other medicines and {INVENTED NAME} Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.
Obvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
Beclometasone dipropionate undergoes a very rapid pre-systemic metabolism via esterase enzymes without involvement of cytochrome P450 system.
Beklometazondipropionat se zelo hitro predsistemsko presnovi z esterazami brez vpletenosti sistema citokroma P450.
The use of beclometasone dipropionate nebuliser suspension in doses exceeding those recommended over a long period of time could lead to the suppression of hypothalamic-pituitary-adrenal (HPA)-axis function.
Dalj časa trajajoča uporaba beklometazondipropionata suspenzije za nebulator v odmerkih, večjih od priporočenih, lahko povzroči supresijo osi hipotalamus-hipofiza-nadledvične žleze (HPA).
Immediately after inhalation the mouth should be rinsed with water to reduce the frequency of fungal infections in the mouth.
Takoj po inhaliranju si morate usta izprati z vodo, da zmanjšate pogostost glivičnih okužb ustne votline.
{INVENTED NAME} nebuliser suspension comes in polyethylene ampoules containing 1 ml ({INVENTED NAME} 400 micrograms) or 2 ml ({INVENTED NAME} 800 micrograms).
Zdravilo {IZMIŠLJENO IME} suspenzija za nebulator je na voljo v polietilenski ampuli, ki vsebuje 1 ml ({IZMIŠLJENO IME} 400 mikrogramov) ali 2 ml ({IZMIŠLJENO IME} 800 mikrogramov).
Method of administration {INVENTED NAME} is for inhalation use only.
Zdravilo {IZMIŠLJENO IME} je namenjeno samo za inhaliranje.
The potency of B17MP is approximately 30-fold higher than the parent compound.
B17MP je približno 30-krat večja od izhodne učinkovine.
Follow the manufacturer's instructions for cleaning your nebuliser.
Za čiščenje nebulatorja upoštevajte navodila izdelovalca.
If you have been taking corticosteroid tablets at high doses or for a long time, your dose may be gradually reduced, approximately one week after you started treatment with {INVENTED NAME}.
Če jemljete velike odmerke kortikosteroidnih tablet ali jih jemljete dalj časa, je treba odmerek postopoma zmanjševati v enotedenskem obdobju po tem, ko ste začeli zdravljenje z zdravilom {IZMIŠLJENO IME}.
Urinary cortisol and the time course of height and weight were unaffected by both treatments and of nebulised beclometasone dipropionate confirmed to have a neutral effect on bone metabolism (Delacourt et al., 2003).
Nobeno od zdravljenj ni vplivalo na kortizol v urinu, ne na telesno višino in telesno maso, vpliv beklometazondipropionata za nebulator na presnovo kosti pa je bil potrjeno nevtralen (Delacourt et al., 2003).
Comparable improvements over baseline were reported at study end for the two treatment groups in morning pulmonary expiratory flow rate (primary endpoint), clinical symptoms scores and the use of rescue salbutamol.
Ob koncu študije so o primerljivem izboljšanju glede na izhodišče poročali za obe skupini bolnikov pri jutranjem pretoku zraka med izdihom (to je bil primarni opazovani dogodek), rezultatih kliničnih simptomov in uporabi rešilnega salbutamola.
ONLY sterile sodium chloride 9 mg/ml (0.9%) solution should be used.
Uporabljati je dovoljeno SAMO sterilno raztopino natrijevega klorida 9 mg/ml (0,9 %).
In this case, empty the contents of the ampoule into the nebuliser bowl then add the quantity of sterile sodium chloride 9 mg/ml (0.9%) solution that your doctor has told you to use.
V tem primeru izpraznite vsebino ampule v posodo nebulatorja in dodajte količino sterilne raztopine natrijevega klorida 9 mg/ml (0,9 %), kot vam je naročil zdravnik.
Regular nebulised beclometasone dipropionate plus rescue salbutamol significantly increased the percentage of symptom-free days (primary endpoint, defined as a lack of wheezing, coughing, shortness of breath and patients/parents nocturnal awakenings in 24 h) (69.6 ± 20.89 [SD]; P = 0.034) vs placebo/rescue salbutamol (61.0 ± 24.83 [SD]) but not vs combination nebulised beclometasone dipropionate /rescue salbutamol (64.9 ± 24.74 [SD]) regardless of the presence of risk factors for developing asthma.
Redno zdravljenje z beklometazondipropionatom za nebulator in uporabo rešilnega salbutamola je signifikantno povečalo odstotek dni brez simptomov (to je bil primarni opazovani dogodek, opredeljen kot odsotnost piskajočega dihanja, kašlja, kratke sape in nočnega zbujanja v 24 urah pri bolnikih/starših) (69,6 ± 20.89 [SD]; p=0,034), v primerjavi s kombinacijo placebo/rešilni salbutamol
The decision to start nebulised beclometasone dipropionate for treatment of recurrent wheezing in children up to 5 years of age should be determined by the severity and frequency of wheezing episodes.
Pri odločitvi za začetek zdravljenja z beklometazondipropionatom za nebulator pri otrocih do 5 leta starosti s ponavljajočim se piskajočim dihanjem je treba upoštevati resnost in pogostnost epizod piskajočega dihanja.
For inhalation use.
Samo za inhaliranje.
The following effects may also occur more likely in children • Sleeping problems, depression or feeling worried, restless, nervous, over-excited or irritable
• težave s spanjem, depresija ali občutek zaskrbljenosti, nemir, živčnost, prevelika vznemirjenost ali razdražljivost.
Vigorously shake and turn the ampoule upside-down in order to make the suspension homogeneous.
Ampulo močno stresajte in obračajte na glavo, da postane suspenzija homogena.
The main product of metabolism is the active metabolite (B17MP).
Glavni presnovni produkt je aktivni presnovek (B17MP).
How to store {INVENTED NAME} 6.
Shranjevanje zdravila {IZMIŠLJENO IME} 6.
A study in which the objective was to compare the efficacy and safety of nebulised beclometasone dipropionate versus fluticasone propionate suspension for nebulization was conducted in 205 adults patients aged 18-65 years with asthma randomized to a 12-week treatment period.
Študijo s ciljem primerjati učinkovitost in varnost beklometazondipropionata za nebulator in suspenzijo flutikazonpropionata za nebulator so opravili pri 205 odraslih bolnikih, starih od 18 do 65
In case of asthma disease, {INVENTED NAME} must be used regularly on a daily basis.
Za zdravljenje astme morate zdravilo {IZMIŠLJENO IME} uporabljati redno vsak dan.
Beclometasone dipropionate is a glucocorticoid with potent anti-inflammatory activity with limited mineralocorticoid activity; following administration to the respiratory system by inhalation a local effect in the lower respiratory tract is obtained.
Beklometazondipropionat je glukokortikoid z močnim protivnetnim delovanjem z omejeno mineralokortikoidno aktivnostjo; po vnosu v dihala z inhaliranjem se razvije lokalni učinek v spodnjih dihalih.
Once half the content is used, reinsert the cap upside down by pushing it onto the container.
Ko uporabite polovico odmerka, zaporko vstavite nazaj tako, da jo obrnete na glavo in potisnete na vsebnik.
Gargling with water immediately after inhalation may help to prevent this effect.
• vnetje žrela (faringitis, laringitis) Z grgranjem vode takoj po inhalaciji boste morda pomagali preprečiti ta učinek.
The pharmacokinetics of BDP in patients with renal or hepatic impairment has not been studied; however, as BDP undergoes a very rapid metabolism via esterase enzymes present in intestinal fluids, serum, lungs and liver to originate more polar products B21MP, B17MP and BOH, hepatic impairment is not expected to modify the pharmacokinetics and safety profile of BDP.
Ker se BDP zelo hitro presnovi z encimi esteraze, ki so prisotni v črevesnih tekočinah, serumu, pljučih in jetrih, v bolj polarne produkte B21MP, B17MP in BOH, se ne pričakuje, da bi okvara jeter spremenila farmakokinetiko in profil varnosti BDP.
In order to obtain a half vial, pour the content into the nebuliser up to the half dose mark indicated on the sides of the vial.
prelijte vsebino v nebulator do oznake za polovico odmerka, ki je označen na ampuli.
During nebulisation
Med uporabo nebulatorja
No evidence of carcinogenicity was observed in a 95-week study in rats treated by inhalation.
V 95-tedenski študiji pri podganah, tretiranih z inhalacijami, niso opazili znakov kancerogenosti.
Rinsing your mouth or gargling with water immediately after inhalation may help to prevent these effects.
• glivična okužba (sor) v ustih, na jeziku in v žrelu Z izpiranjem ust ali grgranjem vode takoj po inhalaciji boste morda pomagali preprečiti te učinke.
The most common adverse reactions observed during clinical trials using inhaled beclometasone in the treatment of asthma and wheezing were laryngitis, pharyngitis and oral candidiasis.
Povzetek varnostnega profila Najpogostejši neželeni učinki z inhalacijskim beklometazonom pri zdravljenju astme in piskajočega dihanja, ki so jih opazili med kliničnimi preskušanji, so bili laringitis, faringitis in kandidoza ustne votline.
Pharmacotherapeutic group: Other drugs for obstructive airway diseases, inhalants; Glucocorticoids ATC code: R03 BA01.
glukokortikoidi Oznaka ATC: R03 BA01.
• worsening shortness of breath, cough and wheezing (which is known as paradoxical bronchospasm).
• slabšanje kratke sape, kašlja in piskajočega dihanja (to je znano kot paradoksni bronhospazem) Če se to pojavi, ne uporabite še enega odmerka zdravila {IZMIŠLJENO
The systemic absorption of the main active metabolite B17MP arises from both lung deposition and oral absorption of the swallowed dose.
Sistemska absorpcija glavnega aktivnega presnovka B17MP poteka iz depozitov v pljučih in peroralne absorpcije zaužitega odmerka.
No specific studies have been performed with beclometasone dipropionate with regard to the safety in human fertility.
Plodnost Posebnih varnostnih študij z beklometazondipropionatom na sposobnost razmnoževanja pri ljudeh niso opravili.
If you develop an immediate increase in wheezing, shortness of breath and cough after using {INVENTED NAME}, you should discontinued immediately {INVENTED NAME} and you should contact your doctor.
Če se vam takoj po uporabi zdravila {IZMIŠLJENO IME} poslabša piskajoče dihanje, kratka sapa in kašelj, takoj prenehajte uporabljati zdravilo {IZMIŠLJENO IME} in se nemudoma posvetujte z zdravnikom.
{INVENTED NAME} should not be injected or administered orally.
Zdravila {IZMIŠLJENO IME} se ne sme injicirati ali dajati peroralno.
The quantity of sterile sodium chloride 9 mg/ml (0.9%) solution required should be added.
Dodati je treba potrebno količino raztopine natrijevega klorida 9 mg/ml (0,9 %).
You may be told that you should not use {INVENTED NAME} again.
Morda vam bo povedal, da prenehate uporabljati zdravilo {IZMIŠLJENO IME}.
Paradoxical bronchospasm may occur after dosing.
Po odmerjanju se lahko pojavi paradoksni bronhospazem.
Perhaps you are more wheezy and short of breath than usual, or your nebuliser seems to be less effective.
• Kaže, da se vaša stanje slabša, npr. če se vaše piskajoče dihanje stopnjuje, imate kratko sapo večkrat kot običajno ali pa je vaš nebulator manj učinkovit.
The vial closed in this way must be stored at 2-8°C (in the refrigerator) and pour the content into the nebuliser up to the graduation mark indicated on the sides of the ampoule.
2◦C do 8◦C (v hladilniku) in vlijte preostalo vsebino v nebulator do oznake, ki je ob straneh ampule.
The renal excretion of BDP and its metabolites is negligible, faecal excretion is the major route of BDP elimination mainly as polar metabolites.
Izločanje BDP in njegovih presnovkov skozi ledvice je zanemarljivo, izločanje z blatom je glavna pot izločanja BDP.
The benefits of the corticosteroid treatment and the possible risks on the growth suppression must be carefully weighed against one another.
Skrbno je treba oceniti prednosti zdravljenja s kortikosteroidom glede na možno tveganje zaviranja rasti.
• If you have an infection of nasal and paranasal cavities you have to be treated with suitable therapies,
• Če imate okužbo nosnih in obnosnih votlin, vas je treba zdraviti s primernimi terapijami, ki pa ne predstavljajo specifičnih kontraindikacij za uporabo zdravila {IZMIŠLJENO IME}.
Nausea, dyspepsia
Bolezni prebavil navzea, dispepsija
• maintenance treatment of asthma, when the use of pressurised metered dose or dry powder inhalers is unsatisfactory or inappropriate, in adults and children up to 18 years of age;
• vzdrževalno zdravljenje astme pri odraslih in otrocih do 18. leta starosti, kadar uporaba inhalatorjev pod tlakom z odmerjenim odmerkom ali inhalatorjev s suhim praškom ni zadovoljiva ali ni primerna,.
No evidence of teratogenic effects in pregnant women using inhaled beclometasone was observed according to published data.
V skladu z objavljenimi podatki pri nosečnicah, ki so uporabljale inhalacijski beklometazon, niso opazili znakov teratogenih učinkov.
If only half dose of {INVENTED NAME} 800 micrograms is needed, hold the ampoule upside down, ensuring that the graduation mark is clearly visible and apply moderate pressure.
Če je potrebna le polovica odmerka zdravila {IZMIŠLJENO IME} 800 mikrogramov, držite ampulo obrnjeno navzdol in se prepričajte, da je oznaka jasno vidna, nato pa zmerno pritisnite.
Driving and using machines {INVENTED NAME} is unlikely to affect your ability to drive and use machines.
Ni verjetno, da bi zdravilo {IZMIŠLJENO IME} vplivalo na sposobnost vožnje in upravljanja strojev.
Then put the top on the nebuliser bowl and shake gently to mix the contents.
Nato posodo nebulatorja prekrijte s pokrovom in vsebino nežno stresajte, da jo premešate.
Vigorously shake and turn the ampoule upside-down in order to mix the suspension.
Ampulo močno stresajte in obračajte na glavo, da se suspenzija premeša.